Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics. The Clinics: Internal Medicine 38-4

  • ID: 3690498
  • Book
  • 240 Pages
  • Elsevier Health Science
1 of 3
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Note: Product cover images may vary from those shown
2 of 3

Loading
LOADING...

3 of 3
Cush, John J Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas
Clinical Professor of Internal Medicine,.

Dao, Kathryn H.
Note: Product cover images may vary from those shown
4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll